How to Institute Pulmonary Rehabilitation for Patients with Chronic Obstructive Pulmonary Disease

Respiratory Health Health Guideline 2014
France English PDF
National

AI-Generated Document Summary

Objectives

Pulmonary rehabilitation is framed as a comprehensive, personalised component of non-pharmacological care for people with chronic obstructive pulmonary disease and other chronic respiratory diseases, including associated health problems. Its overarching purpose is to improve autonomy, functional capacity, health-related quality of life and sustained self-management by expanding access to appropriate rehabilitation and explaining available prescription and delivery options.

  • Provide rehabilitation when dyspnoea, exercise intolerance or limitations in daily activities persist despite optimised pharmacological treatment, and consider it following hospitalisation for an exacerbation.
  • Increase exercise capacity and establish behavioural changes that improve health and quality of life over the long term.
  • Combine exercise training and therapeutic education with smoking cessation, balanced nutrition, psychosocial support and treatment optimisation.
  • Develop patient understanding of disease and treatment, adherence and inhaler technique, vaccination uptake, recognition and management of exacerbations, suitable physical activity, dietary management, and continued participation in leisure and travel activities.
  • Maintain rehabilitation gains through a skills-maintenance programme initiated when initial training ends, recognising that benefits may decline within six to twelve months without continued support.
  • Embed personalised physical activity, therapeutic education, self-management, psychosocial care, dietary support and chest physiotherapy where appropriate into longer-term care.
  • Improve equitable access through local, outpatient and home-based provision, community and sports-sector involvement, and strengthened primary-care follow-up.
  • Strengthen professional capability through multidisciplinary training, increased awareness of rehabilitation, improved identification of eligible patients and exercise-training instruction for physiotherapists.

Implementation

Delivery is based on individual assessment, shared goal-setting and coordinated multidisciplinary care across complementary settings. General practitioners and pulmonologists identify, motivate and guide eligible patients, while programme content and location are adapted to clinical needs, practical constraints, local service availability and patient preferences.

  • Assess patients before rehabilitation through clinical and functional evaluation by a pulmonologist or physical and rehabilitation medicine specialist, with input as relevant from physiotherapists, dietitians, smoking-cessation specialists, psychologists and other professionals.
  • Evaluate dyspnoea, physical activity, tobacco use, quality of life, anxiety, depression, psychosocial circumstances, spirometry at rest, blood gases, exercise electrocardiography, six-minute walk performance, educational needs and comorbidities.
  • Use motivational interviewing to explore patient wishes, beliefs, expectations, concerns and confidence, particularly for smoking cessation, and address barriers including inaccessible services, unsuitable venues or schedules, low confidence and poor adherence.
  • Agree educational objectives jointly with each patient, creating a personalised programme intended to build and preserve practical skills over time.
  • Deliver initial programmes through hospitals, day hospitals, outpatient services, local treatment centres, medical or physiotherapy practices, rehabilitation units, coordinated networks or patients’ homes, while ensuring coordination between all participants.
  • Provide at least 12 rehabilitation sessions, usually 20, over six to 12 weeks, and encourage ongoing physical activity three to five times a week for 30 to 45 minutes alongside continued behavioural change.
  • Use full hospitalisation for initial training where severe comorbidity or instability risk, severe respiratory disease with substantial dependence, psychological or social difficulties, or lack of outpatient provision make this appropriate.
  • Coordinate aftercare through the general practitioner and/or pulmonologist, potentially supported by multidisciplinary protocols and contributions from pharmacists, physiotherapists, suitable-activity instructors, sports physicians, patient associations, family and friends.
  • Support continuity through healthy-living, sports and patient associations, and identify people at risk of non-compliance for closer follow-up, coaching, education and motivational support.
  • Monitor outcomes using dyspnoea scales, exercise-tolerance tests, quality-of-life questionnaires, and assessment of anxiety and depression; repeat the same exercise-tolerance test, such as a six-minute walk or step test, at least annually.
  • Record progress against educational goals as explained, achieved, in progress or not achieved, and use a 0-to-10 confidence scale for smoking cessation, exploring ways to raise confidence where it is below 10.
  • Communicate programme assessments and results to the general practitioner, pulmonologist and other professionals involved in the care pathway.
  • Improve regional organisation by mapping and publicising available rehabilitation resources, developing Regional Healthcare Agency projects, engaging community organisations and establishing a funding framework for the service model.
  • Use proposed regional indicators to compare baseline and one-year numbers of rehabilitation participants and chronic obstructive pulmonary disease education programmes, and to measure the proportion of rehabilitation participants with improved exercise tolerance at one year.

Monitoring & Evaluation

Pulmonary rehabilitation is monitored through repeated clinical, functional, educational and behavioural assessment across the initial programme and long-term aftercare. Evaluation focuses on changes in dyspnoea, exercise capacity, quality of life, mental health, adherence, self-management and progress towards personalised educational goals.

  • Conduct an initial clinical and functional assessment covering dyspnoea, physical activity, tobacco use, quality of life, anxiety, depression, psychosocial circumstances, resting spirometry, blood gases, exercise electrocardiography, six-minute walk testing, educational needs and comorbidities.
  • Assess the rehabilitation programme and its results against the initial evaluation criteria, particularly dyspnoea, exercise tolerance and quality of life, and communicate findings to the general practitioner, pulmonologist and other professionals in the care pathway.
  • Monitor long-term effectiveness with dyspnoea scales, exercise-tolerance tests, quality-of-life questionnaires and assessments of depression and anxiety.
  • Repeat the same exercise-tolerance measure, such as a six-minute walk test or step test, at least annually to enable comparison of progress over time.
  • Record progress against jointly selected educational goals, distinguishing whether each goal was explained, achieved, in progress or not achieved.
  • Assess smoking-cessation confidence on a scale from 0, indicating no confidence in success, to 10, indicating complete confidence, and explore measures that could increase confidence where the score is below 10.
  • Assess adherence regularly, identify people at risk of non-compliance, and provide closer monitoring, targeted coaching, continuing education and support for motivation and sustained behavioural change.
  • Maintain coordinated follow-up through the primary-care team, general practitioner and/or pulmonologist, with multidisciplinary protocols where appropriate and continuing appointments during long-term aftercare.
  • Track proposed regional indicators by comparing, at baseline and one year later, the number of people receiving pulmonary rehabilitation and the number of chronic obstructive pulmonary disease education programmes available.
  • Measure the number of people whose exercise tolerance has improved one year after rehabilitation against the total number who underwent rehabilitation.

Monitoring is therefore principally patient-centred and pathway-based, combining clinical reassessment with adherence and educational follow-up.Formal reporting arrangements, numerical performance targets, audit requirements and wider accountability mechanisms are not specified beyond the proposed indicators, assessment-sharing and coordinated clinical monitoring.

Costing & Financing

Financing detail is limited. A funding framework is proposed for organising pulmonary rehabilitation regionally, alongside development of local provision, coordinated networks and accessible outpatient or home-based options.No quantified budget, unit cost, allocation, funding source, funding gap, resource-mobilisation target or economic assumption is provided for rehabilitation, smoking cessation or patient education.

  • Establish a funding framework to support the regional organisation of pulmonary rehabilitation services.
  • Develop regional capacity by inventorying and publicising available services, supporting local rehabilitation projects and involving community, healthy-living and sports organisations.
  • Use complementary delivery settings, including hospital, local treatment centres, medical or physiotherapy practices, rehabilitation units and patients’ homes, although the source does not attach costs or reimbursement arrangements to these models.

The supplied material identifies service-development and coordination needs but does not specify how staffing, training, facilities, equipment, patient transport, home delivery, network administration or long-term follow-up would be financed.

Document Viewer